In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Francesca Bruce

Francesca Bruce has been writing news and analysis about all things affecting the pharmaceutical industry since 2008. She has paid special attention to policy and regulatory developments but particularly likes to write about market access and how medicines may  - or may not  -  make it to patients. She generally writes about Europe, but really enjoys uncovering news from further corners of the globe, especially Latin America and the Middle East.
Set Alert for Articles By Francesca Bruce

Latest From Francesca Bruce

Bio Industry Warns UK Orkambi Inquiry Against Publishing Confidential Price Information

Vertex and bioindustry groups have called on a UK inquiry investigating the availability of the cystic fibrosis drug Orkambi on the National Health Service not to publish confidential information.

Europe United Kingdom

Mexican Pharma Industry Joins Anti-Corruption Crackdown

The Mexican research-based pharmaceutical industry has pledged to crack down on corruption as the country’s new president says the vice must be eliminated to deliver better health system.

Mexico Government Payers

UK’s NICE Under Fire For New HTA Fees

Fees for appraisals that the health technology assessment body, NICE, will introduce in April could adversely impact companies with medicines for smaller indications, despite a bigger fee reduction for some manufacturers.

Europe United Kingdom

ABPI Code “Tidy Up” Reflects Digital Developments

The Association of the British Pharmaceutical Industry’s revised code of practice reflects digital developments and replaces the 2016 version.

Europe United Kingdom

Biogen Pours Cold Water On Cross Country Spinraza Pricing Talks With Norway And Denmark

Biogen is reluctant to enter joint talks with Norway and Denmark over Spinraza, but expects cross country pricing and reimbursement collaboration could become a fixture.

BioPharmaceutical Europe

Interview: Eucope On Turning Ten, Defending Orphan Incentives And Securing Market Access For Cell And Gene Therapies

Ten years on from its inception, the European Confederation of Pharmaceutical Entrepreneurs is focused on defending the incentives system for developing orphan drugs.

Europe Health Technology Assessment
See All